mots c vs retatrutide MOTS-c Peptide Therapy CT Retatrutide + MOTS-c Peptide Stack

GLP-1 receptor agonists such as semaglutide, liraglutide, and tirzepatide are widely prescribed in the UK for type 2 diabetes and weight management, but their effects on gastric emptying and appetite have important implications for post-operative care

Average weight loss reached 19.7% at the 8mg dose over 48 weeks

Body dissatisfaction often fuels the urge to diet and triggers feelings of guilt and shame, all of which can reinforce restrictive eating patterns and amplify food noise

It was easy to apply, and I felt a gentle warmth

At 24 weeks, mean relative changes from baseline in liver fat were 42.9% (1 mg), 57.0% (4 mg), 81.4% (8 mg), and 82.4% (12 mg), compared with +0.3% in the placebo arm [3]